Inventor · disambiguated record
Mannching Sherry Ku
Also filed as: KU MANNCHING S · KU MANNCHING SHERRY
17 granted patents·21 pending applications·96 citations·filing 1994–2018
93Inventor score
Top patents by PatentIndex Score
38 records- 0191US8022216B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2008·Granted Sep 20, 2011·14 cites·4 claims
- 0289US8394959B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereofLU QINGHONG·Filed 2012·Granted Mar 12, 2013·14 cites·5 claims
- 0389US8173814B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofLU QINGHONG·Filed 2011·Granted May 8, 2012·13 cites·4 claims
- 0488US9139558B2Maleate salts of (E)-N-{4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2013·Granted Sep 22, 2015·9 cites·20 claims
- 0588US7759341B2Polymorph form II of tanaprogetWYETH LLC·Filed 2006·Granted Jul 20, 2010·11 cites·5 claims
- 0686US9630946B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2015·Granted Apr 25, 2017·5 cites·16 claims
- 0785US7968709B2Process for preparing polymorph form II of tanaprogetWYETH LLC·Filed 2010·Granted Jun 28, 2011·7 cites·6 claims
- 0879US8372995B2Crystalline solid forms of tigecycline and methods of preparing sameWYETH LLC·Filed 2006·Granted Feb 12, 2013·4 cites·10 claims
- 0976US8114869B2Polymorph form II of tanaprogetTESCONI MARC SADLER·Filed 2011·Granted Feb 14, 2012·3 cites·1 claims
- 1069US8865689B2Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemiaKU MANNCHING SHERRY·Filed 2012·Granted Oct 21, 2014·2 cites·13 claims
- 1168US8183201B2Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrinCHUANG WOEI-JER·Filed 2011·Granted May 22, 2012·2 cites·21 claims
- 1264US10035788B2Maleate salts of (E)-N-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2017·Granted Jul 31, 2018·0 cites·24 claims
- 1363US8536152B2Methods of using diacerein as an adjunctive therapy for diabetesKU MANNCHING SHERRY·Filed 2011·Granted Sep 17, 2013·1 cites·23 claims
- 1458US2008188540A1Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)WYETH CORP·Filed 2008·Application pending·0 cites
- 1558US2010113541A1Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH LLC·Filed 2009·Application pending·0 cites
- 1655US7683182B2Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH LLC·Filed 2006·Granted Mar 23, 2010·0 cites·13 claims
- 1755US2008199518A1Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolutionWYETH CORP·Filed 2007·Application pending·0 cites
- 1852US7419982B2Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine saltsWYETH CORP·Filed 2006·Granted Sep 2, 2008·0 cites·15 claims
- 1952US2012115858A1Polymorph Form II of TanaprogetTESCONI MARC SADLER·Filed 2012·Application pending·0 cites
- 2051US2007128270A1Pharmaceutical formulations containing 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and method of making the sameWYETH CORP·Filed 2006·Application pending·0 cites
- 2150US2006121109A1Formulations of substituted benzoxazolesWYETH CORP·Filed 2005·Application pending·0 cites
- 2249US2006121111A1Formulations of substituted benzoxazolesWYETH CORP·Filed 2005·Application pending·0 cites
- 2348US8846758B2Methods of decreasing glycosylated hemoglobin in patients with dyslipidemiaKU MANNCHING SHERRY·Filed 2012·Granted Sep 30, 2014·0 cites·3 claims
- 2448US2008188543A1Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)WYETH CORP·Filed 2008·Application pending·0 cites
- 2547US5561121AStable lyophilized thiotepa compositionAMERICAN CYANAMID CO·Filed 1994·Granted Oct 1, 1996·11 cites·7 claims
- 2645US2010069385A1Liquid formulations of phospholipase enzyme inhibitorsWYETH CORP·Filed 2007·Application pending·0 cites
- 2745US2008188542A1Novel indole polymorphsWYETH CORP·Filed 2008·Application pending·0 cites
- 2845US2010113443A1Liquid formulations of phospholipase enzyme inhibitorsWYETH CORP·Filed 2007·Application pending·0 cites
- 2944US2008234340A1Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrileWYETH CORP·Filed 2008·Application pending·0 cites
- 3043US2007191442A1Aqueous Pharmaceutical Formulations of ER-beta Selective LigandsTESCONI MARC S·Filed 2007·Application pending·0 cites
- 3143US2010056520A1Formulations of phospholipase enzyme inhibitorsDONAHUE FRANCES ANNE·Filed 2007·Application pending·0 cites
- 3242US2019380967A1Preparation of microparticles of an active ingredientSAVIOR LIFETEC CORP·Filed 2018·Application pending·0 cites
- 3342US2010093725A1Semi-solid formulations of phospholipase enzyme inhibitorsWYETH CORP·Filed 2007·Application pending·0 cites
- 3442US2021015752A1Methods for producing particles of an active ingredientSAVIOR LIFETEC CORP·Filed 2018·Application pending·0 cites
- 3540US2006121110A1Formulations of substituted benzoxazolesWYETH CORP·Filed 2005·Application pending·0 cites
- 3640US2010216886A1Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamineWYETH CORP·Filed 2007·Application pending·0 cites
- 3739US2006110451A1Formulations of [1,4]diazepino[6,7,1-IJ]quinoline derivativesWYETH CORP·Filed 2005·Application pending·0 cites
- 3836US2019352365A1Expression construct and method for producing proteins of interestSAVIOR LIFETEC CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mannching Sherry Ku files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →